IP Library Granted Patent US 12,465,386
Granted Patent B2
US 12,465,386 · App. 17/608,816 · Granted Nov 11, 2025

Transcatheter valve laceration device and method

Inventors: Benzion Spector (Tel Mond, IL); Raphael Benary (Tel Aviv, IL); Erez Golan (Rehovot, IL)
Assignee: Pi-Cardia Ltd.
A61B17/320016A61B17/320725A61F2/2427A61B2017/00243A61B2017/22097
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,465,386
App. No.
17/608,816
Granted
Nov 11, 2025
Kind
B2
Abstract

A transcatheter valve laceration device ( 10, 100 ) includes a leaflet support frame ( 12, 112 ) and a leaflet cutting assembly ( 14, 114 ), both of which are movably mounted on a guiding structure ( 16, 116 ) and movable between contracted and expanded orientations. In the expanded orientation, a blade protector ( 24, 124 ) of the leaflet support frame ( 12, 112 ) is positioned over a cutting element ( 36, 136 ) of the leaflet cutting assembly ( 14, 114 ).

Claims (18)

1 . A transcatheter valve laceration device comprising:

a leaflet support frame and a leaflet cutting assembly, both of which are movably mounted on a guiding structure and movable between contracted and expanded orientations, wherein said leaflet cutting assembly comprises a cutting element that comprises a sharp blade arm that has a pointed sharp tip at a distal end of said sharp blade arm; and

a blade actuator arm that has one end that pivots with respect to said guiding structure and an opposite end pivotally coupled to said sharp blade arm proximal to said pointed sharp tip; and

wherein in the expanded orientation, a blade protector of said leaflet support frame is positioned over said pointed sharp tip of a cutting element of said leaflet cutting assembly, and said pointed sharp tip is positioned to puncture a leaflet, and said cutting element is configured to cut the leaflet by axial movement of said leaflet cutting assembly.

2 . The transcatheter valve laceration device according to claim 1 , wherein in the expanded orientation, said blade protector is positioned radially outwards with respect to said cutting element.

3 . The transcatheter valve laceration device according to claim 1 , wherein said cutting element is configured to lacerate tissue located between said cutting element and said blade protector.

4 . The transcatheter valve laceration device according to claim 1 , wherein said leaflet cutting assembly comprises support arms coupled to a first biasing device and said leaflet support frame comprises frame arms coupled to a second biasing device, wherein contraction of said first biasing device causes outward movement of said support arms and expansion of said leaflet cutting assembly, and contraction of said second biasing device causes outward movement of said frame arms and expansion of said leaflet support frame.

5 . The transcatheter valve laceration device according to claim 4 , wherein said first biasing device has a stronger biasing force than said second biasing device.

6 . The transcatheter valve laceration device according to claim 1 , wherein a cutting edge of said sharp blade arm faces towards said guiding structure.

7 . A method for lacerating heart tissue comprising:

introducing the device of claim 1 with said leaflet support frame and said leaflet cutting assembly in contracted orientations to a heart;

expanding said leaflet support frame;

expanding said leaflet cutting assembly;

first piercing said heart tissue with said pointed sharp tip of said cutting element; and

afterwards axially moving said leaflet cutting assembly to lacerate heart tissue located between said cutting element and said blade protector.

8 . The method according to claim 7 , comprising lacerating the heart tissue in a TAVR procedure.

9 . The method according to claim 7 , comprising lacerating the heart tissue in a TAVR-in-TAVR procedure.

10 . The method according to claim 7 , comprising lacerating the heart tissue in a tricuspidization procedure.

Assignments (4)
SECURITY INTEREST Recorded Feb 23, 2026
From: PI-CARDIA LTD.
To: KREOS CAPITAL VI (EXPERT FUND) LP
Reel/Frame 074485/0605 →
SECURITY INTEREST Recorded Jun 3, 2025
From: PI-CARDIA LTD.
To: KREOS CAPITAL VI (EXPERT FUND) LP
Reel/Frame 071463/0524 →
SECURITY INTEREST Recorded Jan 8, 2024
From: PI-CARDIA LTD
To: KREOS CAPITAL VI (EXPERT FUND) L.P.
Reel/Frame 066208/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2021
From: SPECTOR, BENZION; BENARY, RAPHAEL; GOLAN, EREZ
To: PI-CARDIA LTD.
Reel/Frame 058019/0009 →
Continuity (3)
Provisional Application 62870068 · Jul 3, 2019
Provisional Application 62849919 · May 19, 2019
Related Publication 20220313303A1 · Oct 6, 2022
References Cited (19)
US 5613937A · Garrison · 1997 [cited by examiner]
US 20050131438A1 · Cohn · 2005 [cited by applicant]
US 20050203549A1 · Realy Vasquez · 2005 [cited by applicant]
US 20100076476A1 · To · 2010 [cited by examiner]
US 20100286719A1 · Paul · 2010 [cited by examiner]
US 20130066346A1 · Pigott · 2013 [cited by examiner]
US 20130116715A1 · Weber · 2013 [cited by examiner]
US 20150359556A1 · Vardi · 2015 [cited by examiner]
US 20160100855A1 · Lemaitre · 2016 [cited by applicant]
US 20160166243A1 · Wilson · 2016 [cited by examiner]
US 20170209160A1 · Pigott · 2017 [cited by examiner]
US 20180000509A1 · Wilson · 2018 [cited by examiner]
US 20180064460A1 · Vardi · 2018 [cited by examiner]
US 20190029790A1 · Bak-Boychuk · 2019 [cited by examiner]
US 20190069920A1 · Astarci et al. · 2019 [cited by applicant]
US 20190209315A1 · Zhang · 2019 [cited by examiner]
US 20190298517A1 · Sanchez et al. · 2019 [cited by applicant]
PCT Search Report and Written Opinion PCT/IB2020/054729, Sep. 11, 2020. [cited by applicant]
Extended European Search Report Application 20809795.6, Jan. 3, 2023. [cited by applicant]